6-chlorouracil: radiolabelled with 36Cl [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 73272 |
| SCHEMBL ID | 317622 |
| SCHEMBL ID | 8639366 |
| MeSH ID | M0131029 |
| Synonym |
|---|
| 2,4(1h,3h)-pyrimidinedione, 6-chloro- |
| 4270-27-3 |
| nsc43265 |
| nsc-43265 |
| 6-chloro-1h-pyrimidine-2,4-dione |
| 6-chlorouracil |
| 6-chloropyrimidine-2,4(1h,3h)-dione |
| AB-323/25048125 |
| nsc210419 |
| nsc-210419 |
| 4-chlorouracil, >=99% |
| C2093 |
| 4-chlorouracil |
| F1923-0053 |
| pkufnwpsfcoslu-uhfffaoysa- |
| inchi=1/c4h3cln2o2/c5-2-1-3(8)7-4(9)6-2/h1h,(h2,6,7,8,9) |
| AKOS004910428 |
| A18768 |
| 6-chloro-1,2,3,4-tetrahydropyrimidine-2,4-dione |
| nsc 210419 |
| nsc 43265 |
| einecs 224-258-0 |
| 6-chloro-2,4-dihydroxypyrimidine |
| 4-chloro-2,6-dihydroxypyrimidine |
| FT-0621096 |
| 7K-912 |
| 6-chloro-2,4(1h,3h)-pyrimidinedione |
| AM20100126 |
| AKOS021983108 |
| 6-chloropyrimidine-2,4-diol |
| CS-B0829 |
| SCHEMBL317622 |
| mfcd00014595 |
| SY011542 |
| 6-chloro-2,4(1h,3h)-pyrimidinedione # |
| 6-chloropyrimidine-2,4-dione |
| 6-chloro-2,4(1h,3h)-pyrimidindione |
| 6-chloro-uracil |
| SCHEMBL8639366 |
| W-106266 |
| 107577-09-3 |
| AC-22512 |
| mfcd00090752 |
| DTXSID70195396 |
| 2,4-pyrimidinediol, 6-chloro- (9ci) |
| FT-0742345 |
| 6-chloro-2,4-(1h,3h)-pyrimidinedione |
| EN300-109879 |
| STL191584 |
| 2,4-pyrimidinediol, 6-chloro- |
| SB55682 |
| SB57727 |
| F11244 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1159607 | Screen for inhibitors of RMI FANCM (MM2) intereaction | 2016 | Journal of biomolecular screening, Jul, Volume: 21, Issue:6 | A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (27.78) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||